Skip to main content

Sonida Senior Living, Inc. (SNDA) Stock Forecast

Data as of Oct 31, 2026

Healthcare · Current price $34.12 (-0.38%)

Consensus Target
$49.40
Upside
+44.8%
Analysts
6
Rating
Buy(2.33)

Price Target Range

Low $43.00Consensus $49.40High $65.00
▲ Current $34.12

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy2
Hold1
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Nov 18, 2025Ronald KamdemMorgan Stanley$28.00-17.9%

SNDA vs Sector & Market

MetricSNDAHealthcare AvgLarge Cap Avg
Analyst Rating2.332.252.41
Analyst Count6819
Target Upside+44.8%+153002.0%+21.5%
P/E Ratio-9.673.4838.49

Revenue Estimates

PeriodLowAvgHigh#
2026-12-31$212M$212M$212M1
2027-03-31$114M$114M$114M1
2027-06-30$118M$118M$118M1
2027-09-30$121M$121M$121M1
2027-12-31$125M$125M$125M1
2028-12-31$397M$397M$397M1

EPS Estimates

PeriodLowAvgHigh#
2026-12-31$-0.27$-0.27$-0.271
2027-03-31$-0.24$-0.24$-0.241
2027-06-30$-0.23$-0.23$-0.231
2027-09-30$-0.22$-0.22$-0.221
2027-12-31$-0.21$-0.21$-0.211
2028-12-31$-2.99$-1.27$0.452

Frequently Asked Questions

What is the analyst consensus for SNDA?

The consensus among 6 analysts covering Sonida Senior Living, Inc. (SNDA) is Buy with an average price target of $49.40.

What is the highest price target for SNDA?

The highest price target for SNDA is $28.00, set by Ronald Kamdem at Morgan Stanley on 2025-11-18.

What is the lowest price target for SNDA?

The lowest price target for SNDA is $28.00, set by Ronald Kamdem at Morgan Stanley on 2025-11-18.

How many analysts cover SNDA?

6 analysts have issued ratings for Sonida Senior Living, Inc. in the past 12 months.

Is SNDA a buy or sell right now?

Based on 6 analyst ratings, SNDA has a consensus rating of Buy (2.33/5) with a +44.8% upside to the consensus target of $49.40.

What are the earnings estimates for SNDA?

Analysts estimate SNDA will report EPS of $-0.27 for the period ending 2026-12-31, with revenue estimated at $212M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.